CRISPR technology, long heralded as a game-changer in genomics, stands on the brink of a major leap forward. For years, its potential has simmered, but now, it's poised to ignite, promising scientific breakthroughs and significant investment opportunities. Several pioneering companies employing CRISPR for editing human genomes are at the forefront of this revolution. Their goal?
Global Market Comments November 16, 2023 Fiat Lux SPECIAL STEM CELL ISSUE Featured Trade: (THE STEM CELLS IN YOUR INVESTMENT FUTURE) (TMO), (REGN)
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Mad Hedge Technology Letter November 15, 2023 Fiat Lux Featured Trade: (CONSIDERING AT INVESTMENT IN FISKER THEN READ THIS) (FSR), (TSLA)
Removing the Chief Accounting Officer and delaying earnings on the day of earnings is a massive red flag for EV start-up Fisker (FSR). Fisker said in a filing that it “determined that it has material weaknesses in the company’s internal control over financial reporting.” Hiring the wrong person for one of the most important jobs
(THE WEARABLE AI IS HERE) November 15, 2023 Hello everyone, The Ai Pin is here. Anyone for a wearable AI this Christmas? Start-Up Company Name: Humane Price: $699 + $24 monthly data subscription to T-Mobile. Subscription includes a cell phone number, unlimited talk, text, and data. When available: Orders can start from November
Global Market Comments November 15, 2023 Fiat Lux Featured Trade: (TESTIMONIAL), (THE IRS LETTER YOU SHOULD DREAD), (PANW), (CSCO), (FEYE), (CYBR), (CHKP), (HACK), (SNE)
2023 is going to end extremely well, thanks to the help of JT! The year started great with almost 15% gains in a few days in January. Then more profits along the way. When it was time to sit in cash, John strongly advised that and to go enjoy the outdoors. During these past two
Mad Hedge Biotech and Healthcare Letter November 14, 2023 Fiat Lux Featured Trade: (REWRITING BIOPHARMA’S TRADITIONAL SCRIPT) (AZN), (JNJ), (BMY), (NVO)
In the high-stakes game of pharmaceutical innovation, AstraZeneca (AZN) isn't just playing to win; it's rewriting the rulebook. A century-old company, born in the quiet labs of 1913 Sweden, AstraZeneca has become a linchpin in today’s cutting-edge medical advances. This isn't merely a story of corporate survival; it's a journey of transformation, emblematic of how
